Article

Fighting AMD through the power of nutrition

Examining how nutrition affects vision, and how physicians need to encourage healthy diets that contain essential nutrients and antioxidants essential for healthy vision.

TAKE-HOME

Examining how nutrition affects vision, and how physicians need to encourage healthy diets that contain essential nutrients and antioxidants essential for healthy vision.

 

Dr. Eggersdorfer

By Manfred Eggersdorfer, PhD

Age-related macular degeneration (AMD) is the leading cause of blindness for people 55 years and older in the United States.[i] A growing body of evidence suggests that nutritional intake of antioxidants-including lutein, zeaxanthin, and omega-3 fatty acids-may help reduce the risk of AMD and improve vision. Eye health professionals can play a key role in educating patients about these antioxidants.

The studies

As Ophthalmology Times has covered, in 2008, the National Eye Institute’s first Age-Related Eye Disease Study (AREDS) demonstrated that oral supplementation with antioxidant vitamins C and E, beta-carotene, and zinc reduced the risk of progression to advanced AMD by 25% in high-risk patients.[ii][iii]

Frederick Ferris, MD, PhD, director of clinical research at the National Eye Institute (NEI) and chairman of the AREDS, said “the AREDS formula is the first demonstrated treatment for people at high risk for developing advanced AMD. Slowing the progression of AMD to its advanced stage will save the vision of many who would otherwise have had serious vision impairment.” iii

The 2013 AREDS2 follow-up study found that long-term use (10 years) of the high-dose antioxidant-plus-zinc formula reduced the risk of developing advanced AMD by 34%.

AREDS2 also studied the impact of a tweaked AREDS formula on the progression of advanced AMD in high-risk patients-in addition to beta-carotene, lutein, and zeaxanthin-which block harmful blue light from damaging the macula. The National Eye Institute chose FloraGLO Lutein for the study because it is the only purified lutein that is the exact same as the lutein molecule found in nature.

The body is unable to produce these antioxidants-lutein and zeaxanthin must come from dietary intake or from supplements.

Participants who took the AREDS formulation with lutein and zeaxanthin had an 18% reduced risk of developing advanced AMD over the 5-year study, and participants who had low levels and intake of lutein and zeaxanthin before the study began were 25% less likely to develop advanced AMD compared to participants with similar dietary intake who were not taking lutein and zeaxanthin supplements.[iv]

 

Educating patients

For best eye health, older adults and adults at risk of vision loss due to AMD should take vitamins containing 10 mg of lutein and 2mg of zeaxanthin.

Yet few Americans are getting the lutein and zeaxanthin they need. In fact, less than half of Americans-41%-are familiar with lutein, and only 6% of Americans have ever heard of zeaxanthin.[v]

What can eye health professionals do to help?

It starts with educating patients. Let them know the important role a balanced diet and multivitamins can play.

Encouraging healthy diets that contain essential nutrients and antioxidants essential for healthy vision, and recommending supplements for nutrients like vitamin E, lutein, and zeaxanthin where diet alone does not meet daily recommendations, is crucial to the sustained health of eye care patients across the United States.

Nearly 8 million Americans are at risk of advanced AMD in their lifetime. vBy educating patients about antioxidant vitamins that can help slow the progression of AMD, eye health professionals can help millions of Americans see better, and see longer.

 

Dr. Manfred Eggersdorfer is Professor for Healthy Ageing at the University Medical Center Groningen and a Senior Vice President and Head for Nutritional Science Advocacy at DSM Nutritional Products.

 

[i]http://www.dsm.com/campaigns/talkingnutrition/en_US/talkingnutrition-dsm-com/2013/05/20130506-areds2-lutein-zeaxanthin-dha-epa-beta-carotene-amd-eye-health.html

[ii]http://www.nei.nih.gov/news/pressreleases/101201.asp

[iii]http://www.ncbi.nlm.nih.gov/pubmed/11594942

[iv]http://www.nei.nih.gov/news/pressreleases/050513.asp

[v] Kelton/DSM Nutritional Products’ Eye Health Survey

 

 

Subscribe to Ophthalmology Times to receive the latest clinical news and updates for ophthalmologists.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.